1. Unlocking Access to Enantiopure Fused Uracils by Chemodivergent [4+2] Cross-Cycloadditions: DFT-Supported Homo-Synergistic Organocatalytic Approach
- Author
-
Claudio Curti, Marco Lombardo, Andrea Sartori, Vincenzo Zambrano, Lucia Battistini, Franca Zanardi, Gloria Rassu, Luigi Pinna, Giorgio Pelosi, Curti C., Rassu G., Lombardo M., Zambrano V., Pinna L., Battistini L., Sartori A., Pelosi G., and Zanardi F.
- Subjects
chemistry.chemical_classification ,Bicyclic molecule ,010405 organic chemistry ,Enantioselective synthesis ,asymmetric synthesi ,Vinylogy ,Iminium ,General Medicine ,General Chemistry ,010402 general chemistry ,01 natural sciences ,Combinatorial chemistry ,Aldehyde ,Catalysis ,Cycloaddition ,0104 chemical sciences ,fused-ring system ,Enantiopure drug ,chemistry ,Organocatalysis ,organocatalysis ,cycloaddition ,heterocycle - Abstract
The discovery of chemical methods enabling the construction of carbocycle-fused uracils which embody a three-dimensional and functional-group-rich architecture is a useful tool in medicinal chemistry oriented synthesis. In this work, an unprecedented amine-catalyzed [4+2] cross-cycloaddition is documented; it involves remotely enolizable 6-methyluracil-5-carbaldehydes and β-aryl enals, and chemoselectively produces two novel bicyclic and tricyclic fused uracil chemotypes in good yields with a maximum level of enantiocontrol. In-depth mechanistic investigations and control experiments support an intriguing homo-synergistic organocatalytic approach, where the same amine organocatalyst concomitantly engages both aldehyde partners in a stepwise eliminative [4+2] cycloaddition, whose vinylogous iminium ion intermediate product may diverge-depending upon conditions-to either bicyclic targets by hydrolysis or tricyclic products by a second homo-synergistic trienamine-mediated stepwise [4+2] cycloaddition.
- Published
- 2020